Repligen
$177.23Change from previous close: −7.80%Absolute change: −$15.00
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $10B
- Enterprise value
- $9.88B
- P/E (trailing 12 months)
- 264.5
- Forward P/E
- 66.9
- PEG
- 1.92
- Price/book
- 4.74
- Price/sales
- 12.7
- EV/EBITDA
- 68.6
- EV/revenue
- 12.6
Profitability and growth
- Gross margin
- 53.8%
- Operating margin
- 9.3%
- Net margin
- 5.3%
- ROE
- 2.0%
- ROA
- 1.4%
- Revenue growth (year over year)
- 11.9%
- Earnings growth (year over year)
- -65.9%
Financial health
- Total cash
- $810.45M
- Total debt
- $690.94M
- Debt/equity
- 0.33
- Current ratio
- 9.05
- Quick ratio
- 7.30
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $189.70
- Median price target
- $187.50
- High price target
- $225.00
- Low price target
- $145.00
- Analysts with a price target
- 20
- Consensus
- Strong buy
- Forward EPS
- $2.65
- EPS estimate, current year
- $2.06
Shares and trading
- Beta
- 1.05
- Average volume
- 1.09M
- Shares outstanding
- 56.44M
- Float
- 53.47M
- Institutional ownership
- 119.5%
- Insider ownership
- 5.2%
- Short interest (% of float)
- 11.9%
- Short ratio (days)
- 6.79